Changeflow GovPing Telecom & Technology USPTO Patent US12582386B2: Aberration Correctio...
Routine Notice Added Final

USPTO Patent US12582386B2: Aberration Corrections for Ultrasound Therapy

Favicon for changeflow.com ChangeBridge: Patent Grants - AI & Computing (G06N)
Published March 24th, 2026
Detected March 24th, 2026
Email

Summary

The USPTO has granted patent US12582386B2 to Insightec Ltd. for a differential prediction method for aberration corrections in ultrasound therapy. The patent utilizes a machine-learning model to optimize focal zones during therapeutic or diagnostic procedures.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582386B2 to Insightec Ltd. This patent covers a novel approach for delivering ultrasound energy to a target region, employing a machine-learning model to predict and compensate for beam aberrations caused by intervening tissue. The system generates optimized focal zones for therapeutic or diagnostic procedures.

This is a patent grant, not a regulatory rule or guidance. It does not impose new compliance obligations on regulated entities. However, it signifies technological advancement in the field of ultrasound therapy and medical devices, potentially influencing future product development and intellectual property strategies for companies in this sector.

Source document (simplified)

← USPTO Patent Grants

Differential prediction of aberration corrections for ultrasound therapy

Grant US12582386B2 Kind: B2 Mar 24, 2026

Assignee

INSIGHTEC LTD.

Inventors

Talia Amar, Yoav Levy

Abstract

Various approaches for delivering ultrasound energy to a target region during a therapeutic or diagnostic procedure includes implementing an adjustment mechanism having a machine-learning model that has been trained, based on input vectors corresponding to a difference and/or a ratio of parameter values between multiple transducer elements, to generate, for each of the transducer elements, one or more parameter value to compensate for expected beam aberration resulting for an intervening tissue; and activating the transducer elements in accordance with the corresponding parameter values so as to generate an optimized focal zone at the target region during the therapeutic or diagnostic procedure.

CPC Classifications

A61B 8/54 A61B 8/08 A61B 8/4461 A61B 8/4488 A61B 8/481 A61N 7/00 A61N 2007/0052 A61N 2007/0078 A61N 2007/0095 A61N 7/02 G06N 3/044 G06N 5/01 G06N 5/02

Filing Date

2021-03-04

Application No.

17909139

Claims

34

View original document →

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582386B2

Who this affects

Applies to
Medical device makers Drug manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Ultrasound Therapy Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
R&D
Topics
Medical Devices Artificial Intelligence

Get Telecom & Technology alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - AI & Computing (G06N) publishes new changes.

Free. Unsubscribe anytime.